Dabigatran

🧮 Dose calculator

Atrial fibrillation / anticoagulation · Regimen source: FDA Dabigatran · 2.2

• • CrCl 15–30: 75 mg twice daily; <15 or dialysis: no recommendation. Do not open or chew capsules. FDA Dabigatran · 2.2

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Dabigatran · 8.1

  “Risk Summary The limited available data on Dabigatran Etexilate Capsules use in pregnant women are insufficient to determine drug-associated risks for adverse developmental outcomes.”

• 🤱 BreastfeedingDangerous / avoid

  Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Dabigatran · 8.2

  “Breastfeeding is not recommended during treatment with Dabigatran Etexilate Capsules.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Dabigatran · 8.4

  “The safety and effectiveness of Dabigatran Etexilate Capsules for the treatment and the reduction in risk of recurrence of venous thromboembolism have been established in pediatric patients 8 to less than 18 years of age.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Dabigatran · 8.5

  “The risk of stroke and bleeding increases with age, but the risk-benefit profile is favorable in all age groups [see Warnings and Precautions (5), Adverse Reactions (6.1), and Clinical Studies (14.1)] .”

• ⚥ Females & males of reproductive potentialUse with caution

  Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Dabigatran · 8.3

  “Females of reproductive potential requiring anticoagulation should discuss pregnancy planning with their physician.”